Performance, intelligence and versatility, the V8 is optimized for use in busy ultrasound departments in the USA and around the world
Designed for a wide range of diagnostic medical ultrasound departments, the V8 Ultrasound system combines performance and intelligence to elevate diagnostic confidence.
Danvers, Massachusetts – October 14, 2021 – NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. The V8 was recently cleared by the U.S. Food and Drug Administration for commercial use in the USA. The feature-packed device includes two new artificial intelligence (AI) functions. The first is "NerveTrack™", an exciting AI technology that detects the location of nerves during live scanning. The second is “UterineAssist”, which detects tissue changes and assists the user with measurements of the uterus.
“We are pleased to launch the V8. We designed it with the user in mind, from its premium imaging engine to its ergonomic design," said David Legg, Vice President, Ultrasound and Digital Radiography, NeuroLogica. “The “V” in “V8” stands for “versatile” because a wide range of departments from obstetrics to radiology and orthopedics to cardiology can make use of its complex functions. We anticipate the V8 to become a flagship product within the high-end ultrasound category.”
Crystal Architecture™ is the core of the V8’s exceptional image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam™), sophisticated image processing (CrystalLive™) and advanced S-Vue Single Crystal Transducers™ to produce clear, uniform and high-resolution images.
Samsung is continuously seeking out new ways to help professionals obtain reliable answers with greater image clarity, enhanced accuracy and improved work efficiency. The V8 is equipped with many premium technologies such as:
- ShadowHDR™, designed to suppress shadows and enhance the clarity of displayed grayscale images.
- S-Shearwave Imaging™, which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity.
- S-Fusion™ technology, which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI, which are instantly reconstructed in the corresponding plane.
- MV-Flow™, which enhances the visualization of low-flow blood flow states.
The V8 also has various 3D, 4D and 5D technologies that allow the user to view anatomy with exceptional detail. One tool, 5D CNS+™, simplifies fetal brain assessment by automatically providing nine planes simultaneously with biometric measurements. The V8 will deliver a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.
Samsung is presenting the V8 ultrasound system at the Society of Diagnostic Medical Sonography’s annual conference in Denver, Colorado from October 14 to 16.
Media Inquiries
Lynne Gagne
NeuroLogica
978.564.8576
lgagne@neurologica.com
Daejin Kang
IR, Samsung Medison
daejin@samsungmedison.com
